{"id":"doxifluridine","rwe":[{"pmid":"41870059","year":"2026","title":"Erratum for Zhang et al., \"Doxifluridine effectively kills antibiotic-resistant Staphylococcus aureus in chronic obstructive pulmonary disease\".","finding":"","journal":"Microbiology spectrum","studyType":"Clinical Study"},{"pmid":"40203453","year":"2025","title":"Purification-Free Bortezomib-Drug Conjugates Optimize Drug Economy and Cancer Therapeutic Synergy.","finding":"","journal":"ACS applied materials & interfaces","studyType":"Clinical Study"},{"pmid":"40163476","year":"2025","title":"Doxifluridine promotes host longevity through bacterial metabolism.","finding":"","journal":"PLoS genetics","studyType":"Clinical Study"},{"pmid":"40045569","year":"2026","title":"Ten-Year Follow-up Clinical Outcomes and the Role of Adjuvant Chemotherapy in HER2-Positive Patients with Microinvasive Breast Cancer.","finding":"","journal":"Cancer research and treatment","studyType":"Clinical Study"},{"pmid":"39768012","year":"2024","title":"Eradication of Cancer Cells Using Doxifluridine and Mesenchymal Stem Cells Expressing Thymidine Phosphorylase.","finding":"","journal":"Bioengineering (Basel, Switzerland)","studyType":"Clinical Study"}],"tags":[{"label":"doxifluridine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Thymidylate synthase","category":"target"},{"label":"TYMS","category":"gene"},{"label":"Active","category":"status"},{"label":"Primary malignant neoplasm of gastrointestinal tract","category":"indication"},{"label":"Antimetabolites","category":"pharmacology"},{"label":"Antimetabolites, Antineoplastic","category":"pharmacology"},{"label":"Antineoplastic Agents","category":"pharmacology"},{"label":"Appetite Stimulants","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Central Nervous System Stimulants","category":"pharmacology"},{"label":"Immunologic Factors","category":"pharmacology"},{"label":"Immunosuppressive Agents","category":"pharmacology"},{"label":"Noxae","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":160.242,"date":"","count":31,"signal":"Dermatitis acneiform","source":"DrugCentral FAERS","actionTaken":"Reported 31 times (LLR=160)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=DOXIFLURIDINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:49:45.801518+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T00:03:12.920146+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:49:53.362157+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DOXIFLURIDINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:49:53.630503+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6567/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:49:54.336179+00:00"}},"allNames":"flutron","offLabel":[],"synonyms":["5-DFUR","doxifluridine","flutron","furtulon"],"timeline":[{"date":"1987-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"aiSummary":"Flutron is a small molecule. Its modality is classified as a small molecule according to ChEMBL.","approvals":[{"date":"1987-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Flutron","ecosystem":[{"indication":"Primary malignant neoplasm of gastrointestinal tract","otherDrugs":[{"name":"floxuridine","slug":"floxuridine","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Thymidylate synthase","targets":[{"gene":"TYMS","source":"DrugCentral","target":"Thymidylate synthase","protein":"Thymidylate synthase"}],"modality":"Small Molecule","drugClass":"doxifluridine","explanation":"","oneSentence":"","technicalDetail":"Flutron (doxifluridine) acts as a competitive inhibitor of thymidylate synthase, preventing the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), thereby disrupting DNA synthesis and cell proliferation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/958","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=DOXIFLURIDINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DOXIFLURIDINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:47:16.314839","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:49:56.009431+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"capecitabine","drugSlug":"capecitabine","fdaApproval":"1998-04-30","genericCount":14,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"floxuridine","drugSlug":"floxuridine","fdaApproval":"1970-12-18","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"fluorouracil","drugSlug":"fluorouracil","fdaApproval":"1962-04-25","genericCount":23,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"folic acid","drugSlug":"folic-acid","fdaApproval":"1946-08-13","genericCount":36,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"gemcitabine","drugSlug":"gemcitabine","fdaApproval":"1996-05-15","patentExpiry":"Jun 28, 2030","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"leucovorin","drugSlug":"leucovorin","fdaApproval":"1952-06-20","patentExpiry":"Dec 23, 2044","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"levomefolic acid","drugSlug":"levomefolic-acid","fdaApproval":"2010-09-24","relationship":"same-target"},{"drugName":"methotrexate","drugSlug":"methotrexate","fdaApproval":"1953-12-07","patentExpiry":"Oct 4, 2026","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"pemetrexed","drugSlug":"pemetrexed","fdaApproval":"2004-02-04","patentExpiry":"Oct 28, 2035","patentStatus":"Patent protected","relationship":"same-target"}],"genericName":"doxifluridine","indications":{"approved":[{"name":"Primary malignant neoplasm of gastrointestinal tract","source":"DrugCentral","snomedId":363745004,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"capecitabine","brandName":"capecitabine","genericName":"capecitabine","approvalYear":"1998","relationship":"same-target"},{"drugId":"floxuridine","brandName":"floxuridine","genericName":"floxuridine","approvalYear":"1970","relationship":"same-target"},{"drugId":"fluorouracil","brandName":"fluorouracil","genericName":"fluorouracil","approvalYear":"1962","relationship":"same-target"},{"drugId":"folic-acid","brandName":"folic acid","genericName":"folic acid","approvalYear":"1946","relationship":"same-target"},{"drugId":"gemcitabine","brandName":"gemcitabine","genericName":"gemcitabine","approvalYear":"1996","relationship":"same-target"},{"drugId":"leucovorin","brandName":"leucovorin","genericName":"leucovorin","approvalYear":"1952","relationship":"same-target"},{"drugId":"levomefolic-acid","brandName":"levomefolic acid","genericName":"levomefolic acid","approvalYear":"2010","relationship":"same-target"},{"drugId":"methotrexate","brandName":"methotrexate","genericName":"methotrexate","approvalYear":"1953","relationship":"same-target"},{"drugId":"pemetrexed","brandName":"pemetrexed","genericName":"pemetrexed","approvalYear":"2004","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT00296322","phase":"PHASE3","title":"Trial of Adjuvant Chemotherapy for Gastric Cancer","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2001-10","conditions":["Stomach Cancer"],"enrollment":528,"completionDate":"2010-03"},{"nctId":"NCT00858429","phase":"PHASE1","title":"Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2009-04-01","conditions":["Liver Cancer","Metastatic Cancer"],"enrollment":18,"completionDate":"2014-07-08"},{"nctId":"NCT00296335","phase":"PHASE3","title":"Trial of Adjuvant Chemotherapy for Gastric Cancer","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2002-02","conditions":["Stomach Cancer"],"enrollment":855,"completionDate":"2009-12"},{"nctId":"NCT00795678","phase":"","title":"Chemotherapeutic Agents in Brain/Breast","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2008-09","conditions":["Breast Cancer","Metastatic Cancer"],"enrollment":10,"completionDate":"2013-04"},{"nctId":"NCT01401075","phase":"PHASE4","title":"RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients","status":"COMPLETED","sponsor":"Abnoba Gmbh","startDate":"2006-03","conditions":["Gastric Cancer"],"enrollment":32,"completionDate":"2008-04"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"010903","UNII":"V1JK16Y2JP","CHEBI":"CHEBI:31521","INN_ID":"4913","UMLSCUI":"C0048808","chemblId":"CHEMBL6567","ChEMBL_ID":"CHEMBL1130","KEGG_DRUG":"D01309","DRUGBANK_ID":"DB12947","PUBCHEM_CID":"18343","MESH_SUPPLEMENTAL_RECORD_UI":"C025034"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"0.35 hours","clearance":"11.0 mL/min/kg","bioavailability":"40%","fractionUnbound":"0.61%","volumeOfDistribution":"0.28 L/kg"},"publicationCount":303,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 23","pmid":"41870059","title":"Erratum for Zhang et al., \"Doxifluridine effectively kills antibiotic-resistant Staphylococcus aureus in chronic obstructive pulmonary disease\".","journal":"Microbiology spectrum"},{"date":"2025 Apr 23","pmid":"40203453","title":"Purification-Free Bortezomib-Drug Conjugates Optimize Drug Economy and Cancer Therapeutic Synergy.","journal":"ACS applied materials & interfaces"},{"date":"2025 Mar","pmid":"40163476","title":"Doxifluridine promotes host longevity through bacterial metabolism.","journal":"PLoS genetics"},{"date":"2026 Jan","pmid":"40045569","title":"Ten-Year Follow-up Clinical Outcomes and the Role of Adjuvant Chemotherapy in HER2-Positive Patients with Microinvasive Breast Cancer.","journal":"Cancer research and treatment"},{"date":"2024 Nov 26","pmid":"39768012","title":"Eradication of Cancer Cells Using Doxifluridine and Mesenchymal Stem Cells Expressing Thymidine Phosphorylase.","journal":"Bioengineering (Basel, Switzerland)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1987-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:49:56.009431+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}